U.S. Orthopedic Biomaterials Market Size & Outlook
Related Markets
U.S. orthopedic biomaterials market highlights
- The U.S. orthopedic biomaterials market generated a revenue of USD 6,516.2 million in 2023 and is expected to reach USD 10,385.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.9% from 2024 to 2030.
- In terms of segment, ceramics & bioactive glass biomaterials was the largest revenue generating material in 2023.
- Polymers Biomaterials is the most lucrative material segment registering the fastest growth during the forecast period.
Orthopedic biomaterials market data book summary
| Market revenue in 2023 | USD 6,516.2 million |
| Market revenue in 2030 | USD 10,385.2 million |
| Growth rate | 6.9% (CAGR from 2024 to 2030) |
| Largest segment | Ceramics & bioactive glass biomaterials |
| Fastest growing segment | Polymers Biomaterials |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Ceramics & Bioactive Glass Biomaterials, Polymers Biomaterials, Calcium Phosphate Cements, Metal Biomaterials, Composites |
| Key market players worldwide | Koninklijke DSM NV, Evonik Industries AG, Stryker Corp, DePuy Synthes, Zimmer Biomet Holdings Inc, Globus Medical Inc Class A, Exactech, Matexcel, AdvanSource Biomaterials Corporation, Invibio, CAM Bioceramics, Heraeus |
Other key industry trends
- In terms of revenue, U.S. accounted for 30.8% of the global orthopedic biomaterials market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. orthopedic biomaterials market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 10,385.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Orthopedic Biomaterials Market Scope
Orthopedic Biomaterials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| CAM Bioceramics | View profile | 11-50 | Leiden, Zuid-Holland, The Netherlands, Europe | https://www.cambioceramics.com |
| Heraeus | View profile | 10001+ | Hanau, Hessen, Germany, Europe | https://www.heraeus.com |
| AdvanSource Biomaterials Corporation | View profile | 11-50 | Wilmington, Massachusetts, United States, North America | http://www.advbiomaterials.com/ |
| Matexcel | View profile | - | Shirley, New York, United States, North America | https://www.matexcel.com/ |
| Exactech | View profile | 501-1000 | Gainesville, Florida, United States, North America | http://www.exac.com |
| Invibio | View profile | 101-250 | Lancaster, Lancashire, United Kingdom, Europe | https://invibio.com/ |
| Globus Medical Inc Class A | View profile | 5000 | 2560 General Armistead Avenue, Audubon, PA, United States, 19403 | https://www.globusmedical.com |
| DePuy Synthes | View profile | 5001-10000 | Raynham, Massachusetts, United States, North America | https://depuysynthes.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Evonik Industries AG | View profile | 33409 | Rellinghauser Strasse 1-11, Essen, NW, Germany, 45128 | https://www.evonik.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Koninklijke DSM NV | View profile | 20682 | Het Overloon 1, P.O. Box 6500, Heerlen, LI, Netherlands, 6411 TE | https://www.dsm.com |
U.S. orthopedic biomaterials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic biomaterials market will help companies and investors design strategic landscapes.
Ceramics & bioactive glass biomaterials was the largest segment with a revenue share of 32.67% in 2023. Horizon Databook has segmented the U.S. orthopedic biomaterials market based on ceramics & bioactive glass biomaterials, polymers biomaterials, calcium phosphate cements, metal biomaterials, composites covering the revenue growth of each sub-segment from 2018 to 2030.
According to the estimates provided by American Academy of Orthopedic Surgeons in 2019, about 700,000 total knee replacement surgeries and 400,000 total hip replacement surgeries were performed in the U.S. As the number of replacement surgeries are increasing, the demand for orthopedic implants is also increasing.
This is further anticipated to drive the market for orthopedic biomaterials. Furthermore, growing prevalence of osteoporosis and osteoarthritis and increasing geriatric population are expected to drive the market over the forecast period.
According to the estimates provided by the National Osteoporosis Foundation (NOF) in 2014, the U.S. has around 54 million people aged 50 and above affected by osteoporosis, arthritis, and various other low bone mass conditions.
Reasons to subscribe to U.S. orthopedic biomaterials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. orthopedic biomaterials market databook
-
Our clientele includes a mix of orthopedic biomaterials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. orthopedic biomaterials market, including forecasts for subscribers. This country databook contains high-level insights into U.S. orthopedic biomaterials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. orthopedic biomaterials market size, by material, 2018-2030 (US$M)
U.S. Orthopedic Biomaterials Market Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
